PortfoliosLab logo
AMT vs. NVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AMT and NVS is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

AMT vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in American Tower Corporation (AMT) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

450.00%500.00%550.00%600.00%650.00%700.00%750.00%800.00%NovemberDecember2025FebruaryMarchApril
594.78%
787.44%
AMT
NVS

Key characteristics

Sharpe Ratio

AMT:

0.92

NVS:

1.01

Sortino Ratio

AMT:

1.40

NVS:

1.43

Omega Ratio

AMT:

1.18

NVS:

1.20

Calmar Ratio

AMT:

0.64

NVS:

0.97

Martin Ratio

AMT:

2.03

NVS:

2.11

Ulcer Index

AMT:

12.35%

NVS:

9.21%

Daily Std Dev

AMT:

27.14%

NVS:

19.17%

Max Drawdown

AMT:

-98.70%

NVS:

-41.72%

Current Drawdown

AMT:

-22.44%

NVS:

-3.90%

Fundamentals

Market Cap

AMT:

$98.69B

NVS:

$219.57B

EPS

AMT:

$6.92

NVS:

$5.87

PE Ratio

AMT:

30.47

NVS:

18.94

PEG Ratio

AMT:

1.33

NVS:

1.30

PS Ratio

AMT:

9.74

NVS:

4.25

PB Ratio

AMT:

29.19

NVS:

4.99

Total Revenue (TTM)

AMT:

$7.97B

NVS:

$39.24B

Gross Profit (TTM)

AMT:

$5.28B

NVS:

$29.47B

EBITDA (TTM)

AMT:

$5.69B

NVS:

$16.05B

Returns By Period

In the year-to-date period, AMT achieves a 15.89% return, which is significantly lower than NVS's 19.39% return. Over the past 10 years, AMT has outperformed NVS with an annualized return of 10.80%, while NVS has yielded a comparatively lower 6.70% annualized return.


AMT

YTD

15.89%

1M

1.21%

6M

-3.75%

1Y

25.97%

5Y*

-0.27%

10Y*

10.80%

NVS

YTD

19.39%

1M

1.82%

6M

2.10%

1Y

17.28%

5Y*

10.29%

10Y*

6.70%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AMT vs. NVS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMT
The Risk-Adjusted Performance Rank of AMT is 7777
Overall Rank
The Sharpe Ratio Rank of AMT is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of AMT is 7676
Sortino Ratio Rank
The Omega Ratio Rank of AMT is 7474
Omega Ratio Rank
The Calmar Ratio Rank of AMT is 7878
Calmar Ratio Rank
The Martin Ratio Rank of AMT is 7373
Martin Ratio Rank

NVS
The Risk-Adjusted Performance Rank of NVS is 7979
Overall Rank
The Sharpe Ratio Rank of NVS is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of NVS is 7676
Sortino Ratio Rank
The Omega Ratio Rank of NVS is 7777
Omega Ratio Rank
The Calmar Ratio Rank of NVS is 8484
Calmar Ratio Rank
The Martin Ratio Rank of NVS is 7474
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AMT vs. NVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for American Tower Corporation (AMT) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for AMT, currently valued at 0.92, compared to the broader market-2.00-1.000.001.002.003.00
AMT: 0.92
NVS: 1.01
The chart of Sortino ratio for AMT, currently valued at 1.40, compared to the broader market-6.00-4.00-2.000.002.004.00
AMT: 1.40
NVS: 1.43
The chart of Omega ratio for AMT, currently valued at 1.18, compared to the broader market0.501.001.502.00
AMT: 1.18
NVS: 1.20
The chart of Calmar ratio for AMT, currently valued at 0.64, compared to the broader market0.001.002.003.004.005.00
AMT: 0.64
NVS: 0.97
The chart of Martin ratio for AMT, currently valued at 2.03, compared to the broader market-5.000.005.0010.0015.0020.00
AMT: 2.03
NVS: 2.11

The current AMT Sharpe Ratio is 0.92, which is comparable to the NVS Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of AMT and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50NovemberDecember2025FebruaryMarchApril
0.92
1.01
AMT
NVS

Dividends

AMT vs. NVS - Dividend Comparison

AMT's dividend yield for the trailing twelve months is around 3.11%, less than NVS's 3.56% yield.


TTM20242023202220212020201920182017201620152014
AMT
American Tower Corporation
3.11%3.53%2.99%2.77%1.78%2.02%1.64%1.99%1.84%2.05%1.87%1.42%
NVS
Novartis AG
3.56%3.84%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%

Drawdowns

AMT vs. NVS - Drawdown Comparison

The maximum AMT drawdown since its inception was -98.70%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for AMT and NVS. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-22.44%
-3.90%
AMT
NVS

Volatility

AMT vs. NVS - Volatility Comparison

American Tower Corporation (AMT) has a higher volatility of 10.76% compared to Novartis AG (NVS) at 9.15%. This indicates that AMT's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%NovemberDecember2025FebruaryMarchApril
10.76%
9.15%
AMT
NVS

Financials

AMT vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between American Tower Corporation and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items